drugset

drugset / Trial / NCT00403949

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

NCT00403949 ↗

Phase 2 Completed 48 enrolled LEO Pharma Bayer · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the efficacy and safety of AzA 15% Gel in the treatment of mild to moderate perioral dermatitis.

Timeline

Start: 2006-11
Primary completion: 2007-03
Completion: 2007-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Azelaic acid	Small molecule	15 %	Topical

Indications